| Literature DB >> 32464057 |
Rui Huang1, Cheng-Hsuan Li1, Roberto Cao-Milán1, Luke D He1, Jessa Marie Makabenta1, Xianzhi Zhang1, Erlei Yu1,2, Vincent M Rotello1.
Abstract
Bioorthogonal catalysis offers a unique strategy to modulate biological processes through the in situ generation of therapeutic agents. However, the direct application of bioorthogonal transition metal catalysts (TMCs) in complex media poses numerous challenges due to issues of limited biocompatibility, poor water solubility, and catalyst deactivation in biological environments. We report here the creation of catalytic "polyzymes", comprised of self-assembled polymer nanoparticles engineered to encapsulate lipophilic TMCs. The incorporation of catalysts into these nanoparticle scaffolds creates water-soluble constructs that provide a protective environment for the catalyst. The potential therapeutic utility of these nanozymes was demonstrated through antimicrobial studies in which a cationic nanozyme was able to penetrate into biofilms and eradicate embedded bacteria through the bioorthogonal activation of a pro-antibiotic.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32464057 PMCID: PMC7339739 DOI: 10.1021/jacs.0c01758
Source DB: PubMed Journal: J Am Chem Soc ISSN: 0002-7863 Impact factor: 15.419